EMANUELE ROBERT MARTIN
Related Filers (3)
Ownership (20)
4
Monday, 7/3/2023
ARTELO BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/27/2022
ARTELO BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 7/26/2021
ARTELO BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/17/2021
ARTELO BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 8/30/2019
ARTELO BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
3
Friday, 6/21/2019
ARTELO BIOSCIENCES, INC.: Initial statement of beneficial ownership of securities
4
Wednesday, 1/6/2016
Mast Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/12/2015
Mast Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/2/2015
Mast Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/20/2014
Mast Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2014
Mast Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/31/2013
Mast Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/18/2013
ADVENTRX PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 12/19/2011
ADVENTRX PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Thursday, 4/28/2011
ADVENTRX PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Thursday, 5/25/2006
AVANIR PHARMACEUTICALS: Statement of changes in beneficial ownership of securities
4
Thursday, 12/8/2005
AVANIR PHARMACEUTICALS: Statement of changes in beneficial ownership of securities
4
Thursday, 9/22/2005
AVANIR PHARMACEUTICALS: Statement of changes in beneficial ownership of securities
4
Friday, 11/12/2004
AVANIR PHARMACEUTICALS: Statement of changes in beneficial ownership of securities
4
Monday, 3/17/2003
AVANIR PHARMACEUTICALS: Statement of changes in beneficial ownership of securities